Economic evaluations of rotavirus immunization for developing countries: a review of the literature

References

• Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull. World Health Organ.81(3), 197–204 (2003).
   PubMed Web of Science ®Google Scholar
• Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis.9(5), 565–572 (2003).
   PubMed Web of Science ®Google Scholar
• Santosham M, Chandran A, Fitzwater S, Fischer-Walker C, Baqui AH, Black R. Progress and barriers for the control of diarrhoeal disease. Lancet376(9734), 63–67 (2010).
   PubMed Web of Science ®Google Scholar
• Parashar UD, Burton A, Lanata C et al. Global mortality associated with rotavirus disease among children in 2004. J. Infect. Dis.200(Suppl. 1), S9–S15 (2009).
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO. Global networks for surveillance of rotavirus gastroenteritis, 2001–2008. Wkly Epidemiol. Rec.83(47), 421–428 (2008).
   Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med.354(1), 11–22 (2006).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med.354(1), 23–33 (2006).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet370(9601), 1757–1763 (2007).
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet376(9741), 606–614 (2010).
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med.362(4), 289–298 (2010).
   PubMed Web of Science ®Google Scholar
• Zaman K, Dang DA, Victor JC et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet376(9741), 615–623 (2010).
   PubMed Web of Science ®Google Scholar
• Expanded Programme on Immunization of the Department of Immunization, Vaccines and Biologicals. Introduction of rotavirus vaccines into national immunization programmes. World Health Organization, Geneva, Switzerland (2009).
   Google Scholar
• Berry SA, Johns B, Shih C, Berry AA, Walker DG. The cost–effectiveness of rotavirus vaccination in Malawi. J. Infect.Dis.202(Suppl), S108–S115 (2010).
   PubMed Web of Science ®Google Scholar
• Wilopo SA, Kilgore P, Kosen S et al. Economic evaluation of a routine rotavirus vaccination programme in Indonesia. Vaccine27(Suppl. 5), F67–F74 (2009).
   PubMed Web of Science ®Google Scholar
• World Bank. World Development Report 1993: Investing in Health. New York: The World Bank, 1993. Oxford University Press, Washington DC, DC, USA (2010).
   Google Scholar
• Fischer TK, Anh DD, Antil L et al. Health care costs of diarrheal disease and estimates of the cost–effectiveness of rotavirus vaccination in Vietnam. J. Infect. Dis.192(10), 1720–1726 (2005).
   PubMed Web of Science ®Google Scholar
• Flem ET, Latipov R, Nurmatov ZS, Xue Y, Kasymbekova KT, Rheingans RD. Costs of diarrheal disease and the cost–effectiveness of a rotavirus vaccination program in Kyrgyzstan. J. Infect. Dis.200(Suppl. 1), S195–S202 (2009).
   PubMedGoogle Scholar
• Isakbaeva ET, Musabaev E, Antil L et al. Rotavirus disease in Uzbekistan: Cost–effectiveness of a new vaccine. Vaccine25(2), 373–380 (2007).
   PubMed Web of Science ®Google Scholar
• Kim SY, Goldie SJ, Salomon JA. Cost–effectiveness of rotavirus vaccination in Vietnam. BMC Public Health9, 29 (2009).
   PubMed Web of Science ®Google Scholar
• Rose J, Hawthorn RL, Watts B, Singer ME. Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis. BMJ339, b3653–b3665 (2009).
   PubMed Web of Science ®Google Scholar
• Wang XY, Riewpaiboon A, von Seidlein L et al. Potential cost–effectiveness of a rotavirus immunization program in rural China. Clin. Infect. Dis.49(8), 1202–1210 (2009).
   PubMed Web of Science ®Google Scholar
• Ortega O, El-Sayed N, Sanders JW et al. Cost–benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt. J. Infect. Dis.200(Suppl. 1), S92–S98 (2009).
   PubMedGoogle Scholar
• Tate JE, Rheingans RD, O’Reilly CE et al. Rotavirus disease burden and impact and cost–effectiveness of a rotavirus vaccination program in kenya. J. Infect. Dis.200(Suppl. 1), S76–S84 (2009).
   PubMed Web of Science ®Google Scholar
• Constenla DO, Linhares AC, Rheingans RD, Antil LR, Waldman EA, da Silva LJ. Economic impact of a rotavirus vaccine in Brazil. J. Health Popul. Nutr.26(4), 388–396 (2008).
   PubMed Web of Science ®Google Scholar
• De la Hoz F, Alvis N, Narvaez J, Cediel N. Potential epidemiological and economic impact of two rotavirus vaccines in Colombia. Vaccine28(22), 3856–3864 (2010).
   PubMedGoogle Scholar
• de Soarez PC, Valentim J, Sartori AM, Novaes HM. Cost–effectiveness analysis of routine rotavirus vaccination in Brazil. Rev. Panam. Salud Publica23(4), 221–230 (2008).
   PubMed Web of Science ®Google Scholar
• Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R. Cost–effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico. BMC Infect. Dis.8, 103–116 (2008).
   PubMedGoogle Scholar
• Chotivitayatarakorn P, Chotivitayatarakorn P, Poovorawan Y. Cost–effectiveness of rotavirus vaccination as part of the national immunization program for Thai children. Southeast Asian J. Trop.Med. Public Health41(1), 114–125 (2010).
   PubMed Web of Science ®Google Scholar
• World Health Organization. Generic protocol for monitoring impact of rotavirus vaccination on gastroenteritis disease burden and viral strains. World Health Organization, Geneva, Switzerland (2009).
   Google Scholar
• Naghipour M, Nakagomi T, Nakagomi O. Issues with reducing the rotavirus-associated mortality by vaccination in developing countries. Vaccine26(26), 3236–3241 (2008).
   PubMed Web of Science ®Google Scholar
• Adam T, Baltussen R, Tan Torres T et al.Making Choices in Health: WHO Guide to Cost–Effectiveness Analysis. World Health Organization, Geneva, Switzerland (2003).
   Google Scholar
• Griffiths U, Rheingans R, Walker D. Guidelines for Estimating the Economic Burden of Diarrhoeal Disease with Focus on Assessing the Costs of Rotavirus Diarrhea. World Health Organization, Geneva, Switzerland (2005).
   Google Scholar
• World Health Organization. Rotavirus vacccination. Wkly Epidemiol. Rec.84, 213–236 (2009).
   Google Scholar
• Flem ET, Kasymbekova KT, Vainio K et al. Rotavirus infection in hospitalized children and estimates of disease burden in Kyrgyzstan, 2005–2007. Vaccine27(Suppl. 5), F35–F39 (2009).
   Google Scholar
• Atherly D, Dreibelbis R, Parashar UD, Levin C, Wecker J, Rheingans RD. Rotavirus vaccination: cost–effectiveness and impact on child mortality in developing countries. J. Infect. Dis.200(Suppl. 1), S28–S38 (2009).
   PubMedGoogle Scholar